Credo Technology growth re-rating

Conviction: 72% · Horizon: 1Y · 2026-06-11
Rapid EBITDA growth can justify a sharp valuation re-rating.

A company trading at a moderate forward EBITDA multiple while expanding EBITDA at several hundred percent can see strong share-price appreciation as investors reprice the durability and scale of its growth.

Instrument Side Target Reason
CRDO Long Strong EBITDA acceleration combined with a still-reasonable forward EBITDA multiple creates room for continued multiple expansion and earnings-driven upside.

Themes

The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.